Studying CALCRL gene expression in larger cohorts and over longer follow-up periods is highly recommended to gain deeper insight into its functional role in oncogenesis and chemoresistance, as well as its potential as a molecular prognostic marker and future therapeutic target.
Khorshied et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: